A three-dimensional spheroidal cancer model based on PEG-fibrinogen hydrogel microspheres

Biomaterials

Volumn 115, Issue , 2017, Pages 141-154

  Pradhan, Shantanu ^a   Clary, Jacob M ^a   Seliktar, Dror ^b   Lipke, Elizabeth A ^a  

^a AUBURN UNIVERSITY   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cancer tissue engineering; Engineered tumor model; MCF7; Tumor microenvironment; Tumor microsphere; Tumor spheroid

Indexed keywords

BIOMIMETICS; CELL MEMBRANES; CELLS; CYTOLOGY; DISEASES; EMULSIFICATION; EMULSIONS; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROGELS; MICROSPHERES; TISSUE ENGINEERING; TUMORS;

EXTRACELLULAR MATRIX COMPONENTS; MALIGNANT TRANSFORMATIONS; MCF7; MULTICELLULAR TUMOR SPHEROIDS; TUMOR MICROENVIRONMENT; TUMOR MODELS; TUMOR SPHEROID; TWO-DIMENSIONAL (2-D) MODEL;

PHYSIOLOGICAL MODELS;

BIOMIMETIC MATERIAL; FIBRINOGEN; MACROGOL; MICROSPHERE; MACROGOL DERIVATIVE;

ARTICLE; CANCER GROWTH; CANCER MODEL; CELL AGGREGATION; CELL ENCAPSULATION; CELL INTERACTION; CELL JUNCTION; CELL NUCLEUS; CELL POLARITY; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; CYTOARCHITECTURE; EMULSION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYDROGEL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT; TUMOR SPHEROID; BATCH CELL CULTURE; CHEMISTRY; DEVICES; EXPERIMENTAL NEOPLASM; HT-29 CELL LINE; MCF-7 CELL LINE; MULTICELLULAR SPHEROID; PATHOLOGY; PROCEDURES; THREE DIMENSIONAL PRINTING; TISSUE ENGINEERING; TISSUE SCAFFOLD;

BATCH CELL CULTURE TECHNIQUES; BIOMIMETIC MATERIALS; EXTRACELLULAR MATRIX; FIBRINOGEN; HT29 CELLS; HUMANS; HYDROGELS; MCF-7 CELLS; MICROSPHERES; NEOPLASMS, EXPERIMENTAL; POLYETHYLENE GLYCOLS; PRINTING, THREE-DIMENSIONAL; SPHEROIDS, CELLULAR; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TUMOR MICROENVIRONMENT;

EID: 84997525239     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.10.052     Document Type: Article

References (59)

1. [1] Allen, M., Louise Jones, J., Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J. Pathol. 223 (2011), 162–176.
2. [2] Krause, S., Maffini, M.V., Soto, A.M., Sonnenschein, C., The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures. BMC Cancer, 10, 2010, 263.
3. [3] Bissell, M.J., Radisky, D.C., Rizki, A., Weaver, V.M., Petersen, O.W., The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 70 (2002), 537–546.
4. [4] Oskarsson, T., Extracellular matrix components in breast cancer progression and metastasis. Breast 22:Suppl. 2 (2013), S66–S72.
5. [5] Staton, C.A., Brown, N.J., Lewis, C.E., The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opin. Biol. Ther. 3 (2003), 1105–1120.
6. [6] Costantini, V., Zacharski, L.R., Memoli, V.A., Kisiel, W., Kudryk, B.J., Rousseau, S.M., Fibrinogen deposition without thrombin generation in primary human breast-cancer tissue. Cancer Res. 51 (1991), 349–353.
7. [7] Kolodziejczyk, J., Ponczek, M.B., The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression. Contemp. Oncol. 17 (2013), 113–119.
8. [8] Rybarczyk, B.J., Simpson-Haidaris, P.J., Fibrinogen assembly, secretion, and deposition into extracellular matrix by MCF-7 human breast carcinoma cells. Cancer Res. 60 (2000), 2033–2039.
9. [9] Sahni, A., Francis, C.W., Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 96 (2000), 3772–3778.
10. [10] Sahni, A., Simpson-Haidaris, P.J., Sahni, S.K., Vaday, G.G., Francis, C.W., Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J. Thromb. Haemost. 6 (2008), 176–183.
11. [11] Smalley, K.S., Lioni, M., Herlyn, M., Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell Dev. Biol. Anim. 42 (2006), 242–247.
12. [12] Pickl, M., Ries, C.H., Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene 28 (2009), 461–468.
13. [13] Baker, B.M., Chen, C.S., Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J. Cell Sci. 125 (2012), 3015–3024.
14. [14] Yamada, K.M., Cukierman, E., Modeling tissue morphogenesis and cancer in 3D. Cell 130 (2007), 601–610.
15. [15] Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., et al. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci. Rep., 6, 2016, 19103.
16. [16] Kelm, J.M., Timmins, N.E., Brown, C.J., Fussenegger, M., Nielsen, L.K., Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol. Bioeng. 83 (2003), 173–180.
17. [17] Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., Kunz-Schughart, L.A., Multicellular tumor spheroids: an underestimated tool is catching up again. J. Biotechnol. 148 (2010), 3–15.
18. [18] Rainaldi, G., Calcabrini, A., Arancia, G., Santini, M.T., Differential expression of adhesion molecules (CD44, ICAM-1 and LFA-3) in cancer cells grown in monolayer or as multicellular spheroids. Anticancer Res. 19 (1999), 1769–1778.
19. [19] Wu, L.Y., Di Carlo, D., Lee, L.P., Microfluidic self-assembly of tumor spheroids for anticancer drug discovery. Biomed. Microdevices 10 (2008), 197–202.
20. [20] Elliott, N.T., Yuan, F., A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J. Pharm. Sci. 100 (2011), 59–74.
21. [21] Lin, R.Z., Chang, H.Y., Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol. J. 3 (2008), 1172–1184.
22. [22] Markovitz-Bishitz, Y., Tauber, Y., Afrimzon, E., Zurgil, N., Sobolev, M., Shafran, Y., et al. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids. Biomaterials 31 (2010), 8436–8444.
23. [23] Mosesson, M.W., Fibrinogen and fibrin structure and functions. J. Thromb. Haemost. 3 (2005), 1894–1904.
24. [24] Pradhan, S., Chaudhury, C.S., Lipke, E.A., Dual-phase, surface tension-based fabrication method for generation of tumor millibeads. Langmuir 30 (2014), 3817–3825.
25. [25] Almany, L., Seliktar, D., Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 26 (2005), 2467–2477.
26. [26] Dikovsky, D., Bianco-Peled, H., Seliktar, D., The effect of structural alterations of PEG-fibrinogen hydrogel scaffolds on 3-D cellular morphology and cellular migration. Biomaterials 27 (2006), 1496–1506.
27. [27] Franco, C.L., Price, J., West, J.L., Development and optimization of a dual-photoinitiator, emulsion-based technique for rapid generation of cell-laden hydrogel microspheres. Acta Biomater. 7 (2011), 3267–3276.
28. [28] Nandakumar, V., Kelbauskas, L., Johnson, R., Meldrum, D., Quantitative characterization of preneoplastic progression using single-cell computed tomography and three-dimensional karyometry. Cytom. Part A 79A (2011), 25–34.
29. [29] White, F.H., Jin, Y., Yang, L., An evaluation of the role of nuclear cytoplasmic ratios and nuclear volume densities as diagnostic indicators in metaplastic, dysplastic and neoplastic lesions of the human cheek. Histol. Histopathol. 12 (1997), 69–77.
30. [30] Ivascu, A., Kubbies, M., Diversity of cell-mediated adhesions in breast cancer spheroids. Int. J. Oncol. 31 (2007), 1403–1413.
31. [31] Loessner, D., Stok, K.S., Lutolf, M.P., Hutmacher, D.W., Clements, J.A., Rizzi, S.C., Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 31 (2010), 8494–8506.
32. [32] Neve, R.M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F.L., Fevr, T., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 10 (2006), 515–527.
33. [33] Rijal, G., Li, W., 3D scaffolds in breast cancer research. Biomaterials 81 (2016), 135–156.
34. [34] Pradhan, S., Hassani, I., Clary, J.M., Lipke, E.A., Polymeric biomaterials for in vitro cancer tissue engineering and drug testing applications. Tissue Eng. Part B, 2016, 10.1089/ten.TEB.2015.0567.
35. [35] Lee, B.H., Tin, S.P., Chaw, S.Y., Cao, Y., Xia, Y., Steele, T.W., et al. Influence of soluble PEG-OH incorporation in a 3D cell-laden PEG-fibrinogen (PF) hydrogel on smooth muscle cell morphology and growth. J. Biomater. Sci. Polym. Ed. 25 (2014), 394–409.
36. [36] Bearzi, C., Gargioli, C., Baci, D., Fortunato, O., Shapira-Schweitzer, K., Kossover, O., et al. PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium. Cell Death Dis., 5, 2014, e1053.
37. [37] Kesselman, D., Kossover, O., Mironi-Harpaz, I., Seliktar, D., Time-dependent cellular morphogenesis and matrix stiffening in proteolytically responsive hydrogels. Acta Biomater. 9 (2013), 7630–7639.
38. [38] Xu, R., Taskin, M.B., Rubert, M., Seliktar, D., Besenbacher, F., Chen, M., hiPS-MSCs differentiation towards fibroblasts on a 3D ECM mimicking scaffold. Sci. Rep., 5, 2015, 8480.
39. [39] Pradhan, S., Hassani, I., Seeto, W.J., Lipke, E.A., PEG-fibrinogen hydrogels for three-dimensional breast cancer cell culture. J. Biomed. Mater. Res. Part A, 2016, 10.1002/jbm.a.35899.
40. [40] Weitzenfeld, P., Kossover, O., Korner, C., Meshel, T., Wiemann, S., Seliktar, D., et al. Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors. J. Leukoc. Biol. 99 (2016), 1009–1025.
41. [41] Liu, T., Winter, M., Thierry, B., Quasi-spherical microwells on superhydrophobic substrates for long term culture of multicellular spheroids and high throughput assays. Biomaterials 35 (2014), 6060–6068.
42. [42] Yoshii, Y., Waki, A., Yoshida, K., Kakezuka, A., Kobayashi, M., Namiki, H., et al. The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation. Biomaterials 32 (2011), 6052–6058.
43. [43] Xu, X., Sabanayagam, C.R., Harrington, D.A., Farach-Carson, M.C., Jia, X.Q., A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics. Biomaterials 35 (2014), 3319–3330.
44. [44] Chen, L., Xiao, Z., Meng, Y., Zhao, Y., Han, J., Su, G., et al. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials 33 (2012), 1437–1444.
45. [45] Huang, Y.J., Hsu, S.H., Acquisition of epithelial-mesenchymal transition and cancer stem-like phenotypes within chitosan-hyaluronan membrane-derived 3D tumor spheroids. Biomaterials 35 (2014), 10070–10079.
46. [46] Huebner, R.J., Ewald, A.J., Cellular foundations of mammary tubulogenesis. Sem. Cell Dev. Biol. 31 (2014), 124–131.
47. [47] Chen, Q.K., Lee, K., Radisky, D.C., Nelson, C.M., Extracellular matrix proteins regulate epithelial-mesenchymal transition in mammary epithelial cells. Differentiation 86 (2013), 126–132.
48. [48] Godde, N.J., Galea, R.C., Elsum, I.A., Humbert, P.O., Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions. J. Mammary Gland. Biol. 15 (2010), 149–168.
49. [49] Nandakumar, V., Kelbauskas, L., Hernandez, K.F., Lintecum, K.M., Senechal, P., Bussey, K.J., et al. Isotropic 3D nuclear morphometry of normal, fibrocystic and malignant breast epithelial cells reveals new structural alterations. PloS One, 7, 2012, e29230.
50. [50] Pienta, K.J., Coffey, D.S., Correlation of nuclear morphometry with progression of breast-cancer. Cancer 68 (1991), 2012–2016.
51. [51] Ladekarl, M., Quantitative histopathology in ductal carcinoma of the breast - prognostic value of mean nuclear size and mitotic counts. Cancer 75 (1995), 2114–2122.
52. [52] Helczynska, K., Kronblad, A., Jogi, A., Nilsson, E., Beckman, S., Landberg, G., et al. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res. 63 (2003), 1441–1444.
53. [53] Le Bras, G.F., Taubenslag, K.J., Andl, C.D., The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression. Cell Adh. Migr. 6 (2012), 365–373.
54. [54] Martin, T.A., Jiang, W.G., Loss of tight junction barrier function and its role in cancer metastasis. Biochim. Biophys. Acta 1788 (2009), 872–891.
55. [55] Kauppila, S., Stenbäck, F., Risteli, J., Jukkola, A., Risteli, L., Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J. Pathol. 186 (1998), 262–268.
56. [56] Lu, P., Weaver, V.M., Werb, Z., The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196 (2012), 395–406.
57. [57] Seo, B.R., Bhardwaj, P., Choi, S., Gonzalez, J., Andresen Eguiluz, R.C., Wang, K., et al. Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Sci. Transl. Med., 7, 2015 301ra130.
58. [58] Bonnans, C., Chou, J., Werb, Z., Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15 (2014), 786–801.
59. [59] Wang, K., Andresen Eguiluz, R.C., Wu, F., Seo, B.R., Fischbach, C., Gourdon, D., Stiffening and unfolding of early deposited-fibronectin increase proangiogenic factor secretion by breast cancer-associated stromal cells. Biomaterials 54 (2015), 63–71.